Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: Analysis of phase II/III trials

British Journal of Radiology

Volumn 78, Issue 934, 2005, Pages 934-938

  Hartley, A ^a   Ho, K F ^a   McConkey, C ^b   Geh, J I ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; IRINOTECAN; METHOTREXATE; MITOMYCIN; OXALIPLATIN; RALTITREXED; TAXANE DERIVATIVE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; INOPERABLE CANCER; MULTIVARIATE ANALYSIS; PATHOLOGICAL COMPLETE RESPONSE; PATIENT MONITORING; PREOPERATIVE CARE; RADIATION DOSE; RECTUM CANCER; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; HUMANS; MULTIVARIATE ANALYSIS; PREOPERATIVE CARE; PRODRUGS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 27744566164     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/86650067     Document Type: Article

References (47)

1. Sauer R. Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer: first results of the German Rectal Cancer Study (CAO/ARO/AIO-94). Int J Radiat Oncol Biol Phys 2003;57:S124.
2. Bujko K, Nowacki M, Naiserowska-Guttmejer A, Bebenek M, Pudeko M, Kryj M, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004;72:15-24.
3. Bosset J, Calais G, Daban A, Collette L, Mineur L, Radosevic-Jelic L, et al. Preoperative chemoradiotherapy (preop XRT-CT) versus preoperative radiotherapy (preop XRT) in rectal cancer: effect of adding CT on the pathological parameters. Report of the 22921 randomised trial conducted by the EORTC radiotherapy group. Pro ASCO Gastrointestinal Symposium 2004;A202.
4. Bhagarva P, Smyczynzki M, Swanson W, Wassef W, Counihan T, Paterson J, et al. Preoperative chemoradiotherapy with weekly paclitaxel for localised rectal cancer. Pro ASCO 2003;A1485.
5. Bosset J, Magnin V, Maingon M, Mantion G, Pelissier E, Mercier M, et al. Preoperative radiochemotherapy in rectal cancer: long term results of a phase II trial. Int J Radiat Oncol Biol Phys 2000;46:323-7.
6. Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomised trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-flurouracil followed by radical surgery. Cancer 1984;53:1811-8.
7. Carau B, Orru P, Orru S, Dessi M, Nagliati M, Lay G, et al. Neoadjuvant radiochemotherapy treatment in locally advanced rectal adenocarcinoma. Tumori 2003;89 (4 Suppl.):7-8.
8. Carraro S, Roca E, Milano C, Pennella E, Sardi M, Rafailovici L, et al. Rectal cancer: preoperative radiochemotherapy with 5-FU, leucovorin and cisplatin. A three year follow up analysis. Pro ASCO 1999:A1073.
9. Carraro S, Roca E, Cartelli C, Rafailovici L, Castillo Odena S, Wasserman E. Radiochemotherapy with short daily infusion of low dose oxaliplatin, leucovorin and 5FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study. Int J Radiat Oncol Biol Phys 2002;54:397-402.
10. Chan A, Wong A, Langevin J, Jenken D, Heine J, Buie D, et al. Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study. Int J Radiat Oncol Biol Phys 2000;48:843-56.
11. Chang H, Jian J, Cheng S, Liu M, Leu S, Wang F, et al. Preoperative concurrent chemotherapy and radiotherapy in rectal cancer patients. J Formos Med Assoc 1998;97: 32-7.
12. Chari R, Tyler D, Anscher M, Russell L, Clary B, Hathorn J, et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778-87.
13. Chau I, Allen M, Cunningham D, Tait D, Brown G, Hill M, et al. Neoadjuvant systemic flurouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer. Br J Cancer 2003;88: 1017-24.
14. Chen E, Mohiuddin M, Brodowsky H, Fishbein G, Marks G. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 1994;30:169-75.
15. Ciabatoni A, Cavallaro A, Potenza A, Colli R, Maurizi F, Micciche F, et al. Preoperative concomitant radiochemotherapy with a 5-flurouracil plus folinic acid bolus in the combined treatment of locally advanced extraperitoneal rectal cancer: a long-term analysis on 27 patients. Tumori 2003;89:157-63.
16. Conzo G, Caraco C, Vacca R, Di Marzo M, Amore A, Muto P, et al. Neoadjuvant chemoradiotherapy in the treatment of rectal cancer: preliminary results. G Chir 2000;21:319-22.
17. De la Torre A, Ramos S, Valcarcel F, Candal A, Regueiro C, Romero J, et al. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1999;45:629-34.
18. Feliu J, Calvilio J, Escribano A, de Castro J, Sanchez M, Mata A, et al. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy. Ann Oncol 2002;13:730-6.
19. Fernandez-Martos C, Aparacio J, Bosch C, Torregrossa D, Campos J, Vicent J, et al. Pre-operative therapy with oraluracil and tegafur (UFT) and concomitant irradiation in operable rectal cancer. Preliminary results of a multicenter phase II study. Pro ASCO 2001;A590.
20. Frykholm G, Pahlman L, Glimelius B. Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001;50:427-34.
21. Galizia E, Antognoli S, Bracci R, Grillo-Ruggieri F, Mantello G, Marmorale C, et al. Preoperative chemotherapy plus concomitant radiotherapy in rectal cancer patients: a phase II study. Pro ASCO 2002;A2374.
22. Gerard J, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 2003;21:1119-24.
23. Grann A, Feng C, Wong D, Saltz L, Paty P, Guillem J, et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001;49:987-95.
24. Kim J, Kim J, Cho M, Song K, Yoon W. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2002;54:402-8.
25. Kim N, Min J, Park J, Yun S, Sung J, Jung H, et al. Intravenous 5-flurouracil versus oral doxifluridine as preoperative concurrent chemoradiation for locally advanced rectal cancer: prospective randomised trials. Jpn J Clin Oncol 2001;31:25-9.
26. Klautke G, Kirchner R, Hopt U, Rainer F. Continuous infusion of 5FU and weekly irinotecan with concurrent radiotherapy as neoadjuvant treatment for locally advanced or recurrent rectal cancer. Pro ASCO 2001;A555.
27. Kocakova I, Spelda S, Svoboda M, Vyzula R, Kocak I, Brancikova D, et al. Combined therapy of locally advanced rectal adenocarcinoma with capecitabine and concurrent radiotherapy. Pro ASCO 2003;A1295.
28. Mermershtain W, Walfisch S, Koretz M, Geffen D, Cohen Y. Preoperative radiochemotherapy treatment in advanced rectal carcinoma. Pro ASCO 1998;A1144.
29. Mehta V, Poen J, Ford J, Edelstain P, Vierra M, Bastidas, et al. Radiotherapy, concomitant protracted-venous-infusion 5-flurouracil and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis Colon Rectum 2001;44:52-8.
30. Mehta V, Cho C, Ford J, Jambalos C, Poen J, Koong A, et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-flurouracil, and weekly CPT-11 followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 2003;55:132-7.
31. Mohiuddin M, Regine W, John W, Hagihara P, McGrath P, Kennedy D, et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000;46:883-8.
32. Ngan S, Burmeister B, Fisher R, Rischin D, Schache D, Kneebone A, et al. Early toxicity from preoperative radiotherapy with continuous infusion 5-flurouracil for resectable adenocarcinoma of the rectum: a phase II trial for the Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2001;50:883-7.
33. Porter H, Anwar S, Grieve R, Carrington B, Shatwell W, Khoo V, et al. Concurrent raltitrexed and radiotherapy for locally advanced rectal carcinoma. Pro ASCO 2003;A1390.
34. Roh M, Petrelli N, Wieand S, Colangelo L, Smith R, Mamounas E, et al. Phase III randomised trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03). Pro ASCO 2001;A490.
35. Ronzoni M, Cozzarini C, Villa E, San Raffaele H. Tumour downstaging and sphincter preservation with preoperative hyperfractionated radiation therapy and concurrent chemotherapy in locally advanced rectal cancer. Pro ASCO 2002;A2299.
36. Seong J, Cho J, Kim N, Min J, Suh C. Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer. Int J Radiat Oncol Biol Phys 2001;50:435-9.
37. Tamberi S, Luppi G, Perrone A, Frezza G, Santantonio M, Emiliani E, et al. Preoperative 5-flurouracil (5-FU) in continuous infusion concurrent to radiotherapy and sphincter preservation in distal rectal adenocarcinoma: results of a multicentre study. Pro ASCO 2001;A2239.
38. Tjandra J, Reading D, McLachlan S, Gunn I, Green M, McLaughlin S, et al. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer. Dis Colon Rectum 2001;44:1113-22.
39. Uzcudun A, Batlle J, Velasco J, Santos M, Carpeno J, Grande A, et al. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin. Dis Colon Rectum 2002;45:1349-58.
40. Valentini V, Coco C, Cellini N, Picciocchi A, Fares M, Rosetto M, et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001;51:371-83.
41. Vicario G, Santori C, Manente P, Gava A, Pastorelli D, Bortolin M, et al. A phase II study of neoadjuvant chemoradiotherapy in patients with adenocarcinoma of the rectum. Pro ASCO 2002;A2363.
42. Wiltshire K, Brierley J, Swallow C, Oza A, Cummings B, Ringash J, et al. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathological complete response and wound complication rates. Pro ASCO Gastrointestinal symposium 2004;A291.
43. Wong S, Sadasiwan C, Erickson B, Ota D, Mulkerin D, Thomas J, et al. A phase II trial of preoperative capecitabine and concurrent radiation for locally advanced rectal cancer. Pro ASCO Gastrointestinal symposium 2004;A281.
44. Yoon W, Choi J, Kin J, Kim T, Lim K, Hwang B, et al. Enhanced tumoricidal effect of preoperative chemoradiation using capecitabine for locally advanced rectal cancer. Pro ASCO 2001;A2165.
45. Janjan N, Crane C, Feig B, Cleary K, Dubrow R, Curley S, et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001;24:107-12.
46. Valentini V, Coco C, Picciocchi A, Morganti A, Trodella L, Ciabattoni A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002;53:664-74.
47. Francois Y, Nemoz C, Baulieux J, Vignal J, Grandjean J, Partensky C, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999;17:2396-402.